Muscarinic receptor antagonists for the treatment of chronic obstructive pulmonary disease

Author： Matera Maria Gabriella Rogliani Paola Cazzola Mario

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.15, Iss.7, 2014-05, pp. : 961-977

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Potential for long-acting muscarinic antagonists in chronic obstructive pulmonary disease

By Joos Guy F

Expert Opinion on Investigational Drugs, Vol. 19, Iss. 2, 2010-02 ,pp. : 257-264

Informa Healthcare

Access to resources Recommend Favorite

Muscarinic Receptor Agonists and Antagonists in the Treatment of Alzheimer's Disease

Current Pharmaceutical Design, Vol. 11, Iss. 26, 2005-10 ,pp. : 3353-3361

Bentham Science Publishers

Access to resources Recommend Favorite

Does a selective muscarinic receptor (M3) antagonist enhance the efficacy through oral delivery in chronic obstructive pulmonary disease patients?

By Naruganahalli Krishna S

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 7, 2007-07 ,pp. : 1127-1130

Informa Healthcare

Access to resources Recommend Favorite

Aclidinium bromide for the treatment of chronic obstructive pulmonary disease

By Cazzola Mario Page Clive P Matera Maria Gabriella

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 9, 2013-06 ,pp. : 1205-1214

Informa Healthcare

Access to resources Recommend Favorite

Levosalbutamol for chronic obstructive pulmonary disease: a treatment evaluation

By Patel Manish Thomson Neil C

Expert Opinion on Pharmacotherapy, Vol. 13, Iss. 7, 2012-05 ,pp. : 1069-1075

Informa Healthcare

Access to resources Recommend Favorite